Cargando…

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions

We performed a real-life analysis of clinical and laboratory parameters, in orally treated T2DM patients aiming at identifying predictors of insulin treatment initiation. Overall, 366955 patients (55.8% males, age 65 ± 11 years, diabetes duration 7 ± 8 years) were followed up between 2004 and 2011....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentile, Sandro, Strollo, Felice, Viazzi, Francesca, Russo, Giuseppina, Piscitelli, Pamela, Ceriello, Antonio, Giorda, Carlo, Guida, Piero, Fioretto, Paola, Pontremoli, Roberto, De Cosmo, Salvatore, the AMD-Annals Study Group
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169213/ https://www.ncbi.nlm.nih.gov/pubmed/30327785 http://dx.doi.org/10.1155/2018/7153087

Ejemplares similares

Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
por: Gentile, Sandro, et al.
Publicado: (2017)

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
por: Viazzi, Francesca, et al.
Publicado: (2017)

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2018)

Metabolic syndrome, serum uric acid and renal risk in patients with T2D
por: Viazzi, Francesca, et al.
Publicado: (2017)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2017)

Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018)

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018)

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
por: Mirijello, Antonio, et al.
Publicado: (2018)

The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
por: Forlani, Gabriele, et al.
Publicado: (2016)

Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative
por: De Cosmo, Salvatore, et al.
Publicado: (2016)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
por: Leoncini, Giovanna, et al.
Publicado: (2020)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
por: Gentile, Sandro, et al.
Publicado: (2016)

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2023)

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020)

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
por: Gentile, Sandro, et al.
Publicado: (2020)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
por: Gentile, Sandro, et al.
Publicado: (2019)

Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
por: Strollo, Felice, et al.
Publicado: (2017)

Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD
por: Guarino, Giuseppina, et al.
Publicado: (2023)

Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey
por: Gentile, Sandro, et al.
Publicado: (2021)

Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
por: Gentile, Sandro, et al.
Publicado: (2020)

Recent Progress in Space Physiology and Aging
por: Strollo, Felice, et al.
Publicado: (2018)

The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study
por: Gentile, Sandro, et al.
Publicado: (2022)

Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study
por: Gentile, Sandro, et al.
Publicado: (2022)

Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
por: Gentile, Sandro, et al.
Publicado: (2020)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020)

The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
por: Gentile, Sandro, et al.
Publicado: (2022)

Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013)

Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney
por: Viazzi, Francesca, et al.
Publicado: (2013)

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
por: Russo, Elisa, et al.
Publicado: (2020)

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
por: Leoncini, Giovanna, et al.
Publicado: (2021)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Chronic kidney disease as a predictor of clinical risk in the elderly
por: Viazzi, Francesca, et al.
Publicado: (2016)

Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient
por: Viazzi, Francesca, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ev6paj4oh2p9u6gkt7sn0uh7j